PT Indofarma Tbk reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was IDR 1,497,851.19 million compared to IDR 749,255.14 million a year ago. Net income was IDR 2,824.6 million compared to net loss of IDR 18,881.52 million a year ago. Basic earnings per share from continuing operations was IDR 0.91 compared to basic loss per share from continuing operations of IDR 6.09 a year ago.